Atria Investments LLC Has $4.01 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Atria Investments LLC grew its holdings in CME Group Inc. (NASDAQ:CME) by 11.2% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,830 shares of the financial services provider’s stock after buying an additional 1,889 shares during the quarter. Atria Investments LLC’s holdings in CME Group were worth $4,005,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in CME. Edgewood Management LLC increased its position in CME Group by 6.1% in the first quarter. Edgewood Management LLC now owns 9,680,066 shares of the financial services provider’s stock worth $1,976,960,000 after purchasing an additional 555,111 shares during the period. Bank of New York Mellon Corp increased its position in CME Group by 17.8% in the first quarter. Bank of New York Mellon Corp now owns 6,640,423 shares of the financial services provider’s stock worth $1,356,174,000 after purchasing an additional 1,004,852 shares during the period. Parnassus Investments CA increased its position in CME Group by 9.7% in the second quarter. Parnassus Investments CA now owns 6,145,717 shares of the financial services provider’s stock worth $1,307,071,000 after purchasing an additional 541,757 shares during the period. Geode Capital Management LLC increased its position in CME Group by 2.3% in the first quarter. Geode Capital Management LLC now owns 5,892,949 shares of the financial services provider’s stock worth $1,200,598,000 after purchasing an additional 135,019 shares during the period. Finally, Ameriprise Financial Inc. increased its position in CME Group by 14.5% in the first quarter. Ameriprise Financial Inc. now owns 3,301,698 shares of the financial services provider’s stock worth $674,301,000 after purchasing an additional 417,809 shares during the period. Institutional investors own 86.19% of the company’s stock.

A number of analysts recently commented on the company. Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price objective for the company in a research report on Tuesday. Morgan Stanley raised their target price on CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a report on Thursday, July 1st. Berenberg Bank restated a “hold” rating on shares of CME Group in a report on Wednesday. Finally, TheStreet cut CME Group from a “b” rating to a “c+” rating in a report on Wednesday, August 18th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $210.83.

In other CME Group news, insider Sean Tully sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total value of $1,001,000.00. Following the sale, the insider now owns 23,479 shares in the company, valued at approximately $4,700,495.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin J. Gepsman sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, August 30th. The shares were sold at an average price of $201.00, for a total value of $201,000.00. Following the completion of the sale, the director now owns 27,368 shares in the company, valued at approximately $5,500,968. The disclosure for this sale can be found here. Insiders have sold a total of 9,000 shares of company stock worth $1,786,150 in the last quarter. 0.30% of the stock is currently owned by company insiders.

NASDAQ:CME opened at $188.85 on Wednesday. CME Group Inc. has a fifty-two week low of $146.89 and a fifty-two week high of $221.82. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $67.82 billion, a PE ratio of 35.30 and a beta of 0.43. The business’s 50-day simple moving average is $204.38 and its 200-day simple moving average is $208.14.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.59 by $0.05. CME Group had a return on equity of 8.33% and a net margin of 41.64%. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.17 billion. On average, research analysts expect that CME Group Inc. will post 6.65 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 27th. Stockholders of record on Friday, September 10th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.91%. The ex-dividend date is Thursday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 53.57%.

CME Group Company Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Featured Story: Dividend Aristocrat Index

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.